Monika Fischer

8.5k total citations · 2 hit papers
142 papers, 3.8k citations indexed

About

Monika Fischer is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Monika Fischer has authored 142 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Infectious Diseases, 66 papers in Epidemiology and 49 papers in Surgery. Recurrent topics in Monika Fischer's work include Clostridium difficile and Clostridium perfringens research (86 papers), Microscopic Colitis (61 papers) and Gut microbiota and health (34 papers). Monika Fischer is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (86 papers), Microscopic Colitis (61 papers) and Gut microbiota and health (34 papers). Monika Fischer collaborates with scholars based in United States, Canada and United Kingdom. Monika Fischer's co-authors include David W. Crabb, Jessica R. Allegretti, Min You, Colleen Kelly, Mark A. Deeg, Zain Kassam, Benjamin H. Mullish, Brian Sipe, Andrea Galli and Michinaga Matsumoto and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Gastroenterology.

In The Last Decade

Monika Fischer

133 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections

2021 313 citations Colleen Kelly, Monika Fischer et al. The American Journal of Gastroenterology profile →
The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications

2019 250 citations Jessica R. Allegretti, Benjamin H. Mullish et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Monika Fischer United States	30	1.9k	1.8k	1.3k	901	850	142	3.8k
Francesca Romana Ponziani Italy	39	2.1k 1.1×	532 0.3×	1.8k 1.4×	1.0k 1.2×	280 0.3×	178	5.1k
Johannes R. Hov Norway	36	1.2k 0.6×	513 0.3×	1.8k 1.4×	1.1k 1.2×	359 0.4×	118	4.2k
Benjamin H. Mullish United Kingdom	33	1.1k 0.6×	1.7k 0.9×	2.2k 1.7×	673 0.7×	701 0.8×	135	3.8k
Kalyani Daita United States	14	2.4k 1.3×	400 0.2×	1.9k 1.5×	612 0.7×	213 0.3×	22	3.7k
Oren Shibolet Israel	40	2.5k 1.3×	705 0.4×	1.1k 0.8×	868 1.0×	89 0.1×	153	5.6k
Rubén Francés Spain	36	2.4k 1.3×	439 0.2×	1.3k 1.0×	699 0.8×	120 0.1×	115	4.3k
Marius Trøseid Norway	32	926 0.5×	856 0.5×	1.9k 1.4×	470 0.5×	200 0.2×	126	3.9k
Francesco Luzza Italy	32	1.2k 0.6×	225 0.1×	707 0.5×	1.5k 1.7×	515 0.6×	232	4.3k
Andrea De Gottardi Switzerland	34	2.8k 1.5×	291 0.2×	1.3k 1.0×	1.2k 1.3×	125 0.1×	99	4.9k
Bangmao Wang China	31	475 0.3×	483 0.3×	1.9k 1.4×	613 0.7×	665 0.8×	100	3.4k

Countries citing papers authored by Monika Fischer

Since Specialization

Citations

This map shows the geographic impact of Monika Fischer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monika Fischer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monika Fischer more than expected).

Fields of papers citing papers by Monika Fischer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monika Fischer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monika Fischer. The network helps show where Monika Fischer may publish in the future.

Co-authorship network of co-authors of Monika Fischer

This figure shows the co-authorship network connecting the top 25 collaborators of Monika Fischer. A scholar is included among the top collaborators of Monika Fischer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monika Fischer. Monika Fischer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Alonso, Carolyn D., et al.. (2025). Safety and Efficacy of Fecal Microbiota, Live-jslm, in Preventing Recurrent Clostridioides difficile Infection in Participants Who Were Mildly to Moderately Immunocompromised in the Phase 3 PUNCH CD3-OLS Study. Open Forum Infectious Diseases. 12(4). ofaf117–ofaf117.

2.

Travis, Simon, Tadakazu Hisamatsu, Monika Fischer, et al.. (2024). OP12 Mirikizumab improves fatigue, bowel urgency, and quality of life in patients with moderately to severely active Crohn’s Disease: Results from a phase 3 clinical trial. Journal of Crohn s and Colitis. 18(Supplement_1). i21–i23. 5 indexed citations

3.

Fischer, Monika, et al.. (2024). Prevalence of celiac disease in systemic lupus erythematosus, sjogren syndrome and systemic sclerosis: A systematic review and meta-analysis. Digestive and Liver Disease. 56(9). 1475–1482. 4 indexed citations

4.

Shen, Bo, María T. Abreu, Erica Cohen, et al.. (2024). Endoscopic diagnosis and management of adult inflammatory bowel disease: a consensus document from the American Society for Gastrointestinal Endoscopy IBD Endoscopy Consensus Panel. Gastrointestinal Endoscopy. 101(2). 295–314. 8 indexed citations

5.

Dubberke, Erik R., et al.. (2023). 700 SAFETY AND EFFICACY OF RBX2660 IN REDUCING RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION IN IMMUNOCOMPROMISED PARTICIPANTS. Gastroenterology. 164(6). S–142. 1 indexed citations

6.

Herfarth, Hans, Anita Afzali, Monika Fischer, et al.. (2023). Clinical Long-Term Outcomes of Patient-Reported Outcomes in the Prospective Real-World Tofacitinib Response in Ulcerative Colitis Registry. Clinical and Translational Gastroenterology. 15(3). e00669–e00669. 1 indexed citations

7.

Shah, Chirag, et al.. (2023). S938 Clinical Outcomes of Endoscopic Balloon Dilation for Upper Gastrointestinal Crohn’s Disease-Associated Strictures: A Cohort Study. The American Journal of Gastroenterology. 118(10S). S702–S703. 1 indexed citations

8.

Vaughn, Byron P., Monika Fischer, Colleen Kelly, et al.. (2022). Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection. Clinical Gastroenterology and Hepatology. 21(5). 1330–1337.e2. 31 indexed citations

9.

Long, Millie D., Anita Afzali, Monika Fischer, et al.. (2022). Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting. Inflammatory Bowel Diseases. 29(4). 570–578. 18 indexed citations

10.

Zhu, Jinyi, Thomas R. McCarty, Zain Kassam, et al.. (2021). Cost‐effectiveness analysis of sequential fecal microbiota transplantation for fulminant Clostridioides difficile infection. Journal of Gastroenterology and Hepatology. 36(9). 2432–2440. 6 indexed citations

11.

Sands, Bruce E., Laurent Peyrin‐Biroulet, Jarosław Kierkuś, et al.. (2021). Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn’s Disease. Gastroenterology. 162(2). 495–508. 109 indexed citations

12.

Allegretti, Jessica R., Colleen Kelly, Ari Grinspan, et al.. (2020). Outcomes of Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Diseases and Recurrent Clostridioides difficile Infection. Gastroenterology. 159(5). 1982–1984. 29 indexed citations

13.

Santiago, Marina, Jessica R. Allegretti, Olga C. Aroniadis, et al.. (2019). Microbiome predictors of dysbiosis and VRE decolonization in patients with recurrent C. difficile infections in a multi-center retrospective study. PMC. 3 indexed citations

14.

Rex, Douglas K., Sashidhar Sagi, William R. Kessler, et al.. (2019). A comparison of 2 distal attachment mucosal exposure devices: a noninferiority randomized controlled trial. Publisher. 1 indexed citations

15.

Rex, Douglas K., William R. Kessler, Sashidhar Sagi, et al.. (2019). Impact of a ring fitted cap on insertion time and adenoma detection: a randomized controlled trial. Publisher. 1 indexed citations

16.

Rex, Douglas K., Sashidhar Sagi, William R. Kessler, et al.. (2019). A comparison of 2 distal attachment mucosal exposure devices: a noninferiority randomized controlled trial. Gastrointestinal Endoscopy. 90(5). 835–840.e1. 12 indexed citations

17.

Fischer, Monika, Colleen Kelly, Emmalee Phelps, et al.. (2017). Quality of Bowel Preparation does not Affect Outcome of Fecal Microbiota Transplantation for the Therapy Clostridium Difficile Infection. Gastroenterology. 152(5). S1004–S1005. 2 indexed citations

18.

Ali, Rabia, Frederick K. Shieh, David L. Diehl, et al.. (2015). Deep enteroscopy with a conventional colonoscope: initial multicenter study by using a through-the-scope balloon catheter system. Gastrointestinal Endoscopy. 82(5). 855–860. 26 indexed citations

19.

Fischer, Monika & Hala M. Fadda. (2015). The Effect of Sex and Age on Small Intestinal Transit Times in Humans. Journal of Pharmaceutical Sciences. 105(2). 682–686. 24 indexed citations

20.

Fischer, Monika, Min You, Michinaga Matsumoto, & David W. Crabb. (2003). Peroxisome Proliferator-activated Receptor α (PPARα) Agonist Treatment Reverses PPARα Dysfunction and Abnormalities in Hepatic Lipid Metabolism in Ethanol-fed Mice. Journal of Biological Chemistry. 278(30). 27997–28004. 241 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact